Sertraline and Protein C: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Sertraline
No brand names on recordProtein C
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Taking sertraline with Protein C (Ceprotin) can raise your chance of bleeding. Sertraline is an antidepressant that makes it a little harder for your blood cells (platelets) to stick together and stop bleeding. Protein C is used to help prevent clots, so it also works against clotting. Together, these two can add up and make bruising or bleeding more likely.
Watch for things like frequent nosebleeds, easy bruising, or bleeding that is hard to stop. This is manageable. Your care team can keep a closer eye on you and adjust things as needed, so please keep taking both as prescribed and tell your pharmacist or doctor about any unusual bleeding.
Effect: Additive bleeding risk when sertraline is combined with Protein C concentrate (Ceprotin).
Mechanism: SSRIs deplete platelet serotonin, impairing platelet-mediated hemostasis; combined with an anticoagulant agent this produces additive pharmacodynamic effects on hemostasis (no CYP prodrug pathway involved here).
- Direction: Increased bleeding risk (PD, not PK).
- Onset: Delayed.
- Evidence: Probable; supported by case-control and cohort data for SSRI plus anticoagulant.
- Severity: Major.
- Management: Monitor for epistaxis, ecchymosis, hematoma, petechiae, and overt hemorrhage; counsel patient; individualize therapy and monitor more closely.
What happens
An increased risk of bleeding
Interaction Deep Dive
If sertraline is administered together with an anticoagulant, watch the patient for indications of heightened bleeding and warn patients that their bleeding risk is elevated.1. Hemostasis depends in part on platelets releasing serotonin. Studies using case-control and cohort designs have demonstrated that taking SSRIs (sertraline among them) alongside anticoagulants carries an association with a greater risk of bleeding 231. Using sertraline at the same time as an anticoagulant can heighten the likelihood of bleeding. Among the bleeding events that have been documented are epistaxis, ecchymosis, hematoma, petechiae, and hemorrhages that threaten life 1.
Why it happens (mechanism)
Release of serotonin by platelets; additive effects on hemostasis
How to manage this interaction
This interaction is usually managed with closer monitoring rather than stopping either drug.
- Keep taking both exactly as prescribed unless your care team tells you otherwise.
- Watch for bleeding signs: nosebleeds, easy bruising, blood spots under the skin, or bleeding that does not stop.
- Your team may monitor you more closely and adjust and individualize your therapy based on how you respond.
Report any unusual or heavy bleeding to your pharmacist or prescriber right away, and mention all medicines and supplements you take so they can watch for anything that adds to bleeding risk.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
4 reports — tap to read
a) A retrospective cohort study (n=234) reported a heightened risk of clinically relevant bleeding (hospital admission because of bleeding) among patients taking warfarin for atrial fibrillation while also on SSRI therapy or within 2 weeks after stopping SSRI therapy. Patients with a mean age of 72 +/- 7 years who received warfarin plus SSRI (n=117) were matched to randomly chosen patients who received warfarin alone (n=117). The SSRIs comprised FLUoxetine, citalopram, PARoxetine, sertraline, fluvoxaMINE, or escitalopram. In the warfarin plus SSRI group, nine patients had 11 bleeding episodes across 213.9 treatment years, whereas in the warfarin-only group, 10 patients had 14 bleedings across 586.4 treatment years. The respective total incidences of bleedings were 51.4 and 23.9 per 1000 treatment years. Compared with warfarin only, the hazard ratio for first bleedings during warfarin plus SSRI treatment was 3.49 (95% CI; 1.37 to 8.91, p=0.009). Among patients who bled during concomitant use, the SSRIs involved were sertraline or citalopram. Adding an SSRI was not linked to a change in warfarin dose or INR (p=0.48 and p=0.31 respectively). The study findings may be constrained by prior bleeding events, uncertain patient adherence, and the exclusion from the model of clopidogrel, dipyridamol, corticosteroids and anticoagulants other than warfarin 2.
b) A population-based, case-controlled study of patients newly starting coumarins (acenocoumarol and phenprocoumon) together with selective serotonin reuptake inhibitors (SSRIs) found an increased risk of hospitalization for non-gastrointestinal bleeding. Drawing on national pharmacy and hospitalization records in the Netherlands, investigators identified 1848 cases admitted for abnormal bleeding and compared them to 5818 control subjects who were also taking a coumarin. The median treatment duration in patients was 220 days (range, 1 to 4690 days). Patients receiving SSRIs had a greater risk of hospitalization for non-gastrointestinal bleeding (adjusted odds ratio (OR) 1.7, 95% confidence interval (CI), 1.1 to 2.5); however, the rate of gastrointestinal bleeding (adjusted OR 0.8, 95% CI, 0.4 to 1.5) did not differ significantly 3.
c) In a non-blinded, randomized, placebo-controlled trial with 12 healthy volunteers, the influence of sertraline on the plasma protein binding of warfarin was evaluated. On days and 32 of the study, all participants were given warfarin 0.75 mg/kg. Starting on day 11, each volunteer was randomized to the sertraline or the placebo group; the sertraline dose was progressively raised from 50 mg/day to 200 mg/day. Prothrombin time was checked before every warfarin dose and at intervals afterward. The investigators concluded that sertraline did not enhance warfarin's anticoagulant effects to a clinically significant degree, even though sertraline was administered at a higher-than-usual dose 4.
d) Case reports and epidemiological studies (case-control and cohort studies) have shown a link between the use of drugs that interfere with serotonin reuptake and the occurrence of gastrointestinal bleeding. According to data from published observational studies, exposure to SSRIs, especially in the month prior to delivery, has been associated with a less than 2-fold rise in the risk of postpartum hemorrhage. Bleeding events associated with SSRIs and SNRIs have ranged from ecchymosis, hematoma, epistaxis, and petechiae to life-threatening hemorrhages 1.
Common questions
Can I take Sertraline and Protein C together?
Combining sertraline with Protein C (Ceprotin) can add to your bleeding risk, so watch for unusual bleeding or bruising and keep your care team informed while they monitor you. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Sertraline and Protein C interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "delayed". Effects tend to build up gradually over days to weeks.
How is the Sertraline and Protein C interaction managed?
This interaction is usually managed with closer monitoring rather than stopping either drug. Keep taking both exactly as prescribed unless your care team tells you otherwise. Watch for bleeding signs: nosebleeds, easy bruising, blood spots under the skin, or bleeding that does not stop. Your team may monitor you more closely and adjust and individualize your therapy based on how you respond. Repor… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Sertraline or Protein C need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (4)
- Product Information: ZOLOFT oral tablets, oral solution, sertraline hydrochloride oral tablets, oral solution. Viatris Specialty LLC (per FDA), Morgantown, WV, 2023. DailyMed
- Wallerstedt SM, Gleerup H, Sundstrom A, et al: Risk of clinically relevant bleeding in warfarin-treated patients-influence of SSRI treatment. Pharmacoepidemiol Drug Saf 2009; 18(5):412-416. DOI
- Schalekamp T, Klungel OH, Souverein PC, et al: Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarins. Arch Intern Med 2008; 168(2):180-185. PubMed
- Apseloff G, Wilner K, Gerber N, et al: Effect of sertraline on protien binding of warfarin. Clin Pharmacokinet 1997; 32 (suppl. 1):37-42.
Keep reading about Sertraline
Keep reading about Protein C
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist